We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 1,616

Pfizer’s LYRICA patent sufficient, valid and infringed in Australia (but not in the UK)
  • Davies Collison Cave
  • Australia, United Kingdom
  • November 28 2016

In the recent decision of Apotex Pty Ltd v Warner-Lambert Company LLC (No 2) 2016 FCA 1238, the Federal Court has upheld the validity of Pfizer's


Carving out the principles: a comparative review of the Australia and UK Lyrica cases
  • Clayton Utz
  • Australia
  • November 22 2016

On 21 October 2016, the Federal Court of Australia handed down its judgment in the case of Apotex Pty Ltd v Warner-Lambert Company LLC (No 2) 2016


Being litigation ready: Getting Australian patent ownership and licensing right
  • Shelston IP Pty Ltd
  • Australia
  • November 18 2016

Ownership and licensing arrangements relating to an Australian patent can have significant implications in infringement and revocation proceedings


A comparative study of strategies for patenting human therapeutics in the Asia Pacific Region: Part 1 - Australia
  • Fisher Adams Kelly Callinans
  • Australia
  • November 16 2016

In the last century, innovations in the life sciences have allowed for treatment and prevention of numerous diseases and disorders, enabling higher


The new exclusive club of patent enforcement
  • Minter Ellison
  • Australia
  • November 8 2016

In a relatively recent flurry of decisions, the Federal Court examined a variety of agreements purporting to give exclusive rights to various


Showing your hand: don't let patent co-inventorship arise by accident
  • Clayton Utz
  • Australia
  • November 2 2016

Whether someone is a co-inventor will be determined by their qualitative contribution to the inventive concept. Parties should put arrangements in


Not One But Two Decisions Fine Tune The Australian Patent Office’s Approach To Life Science Technologies
  • Watermark Patent & Trade Marks Attorneys
  • Australia
  • October 28 2016

Two recent Australian Patent Office decisions have provided clarity as to the patentability of isolated nucleic acid sequences following the High


Treading carefully with patent infringement notifications in Australia
  • Spruson & Ferguson
  • Australia
  • October 28 2016

The recent case of CQMS Pty Ltd v Bradken Resources Pty Limited has reinforced the need for patent owners to tread carefully if they believe their


Court smells a rat in sufficiency argument
  • Phillips Ormonde Fitzpatrick
  • Australia
  • October 27 2016

The Full Court decision on sufficiency in Tramanco v BPW Transpec (reported here) has now been applied to claims for methods of medical treatment in


Patenting in Canada: Do These Genes Fit?
  • Blake Cassels & Graydon LLP
  • Australia, Canada, USA
  • October 27 2016

The Supreme Court of Canada has commented on the issue but no Canadian court has directly answered the difficult question of whether genes are